Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.72 USD | +3.07% | -1.61% | +14.29% |
Feb. 27 | North American Morning Briefing : Stock Futures -2- | DJ |
Feb. 26 | Citigroup Adjusts Price Target on Cogent Biosciences to $13 From $11, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.29% | 678M | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |
- Stock
- Equities
- Stock Cogent Biosciences, Inc. - Nasdaq
- News Cogent Biosciences, Inc.
- Wedbush Adjusts Price Target for Cogent Biosciences to $17 From $21, Maintains Outperform Rating